FDA Reconsiders Curbs on Avandia

FDA documents suggest the agency is considering reviving a drug that has been highly restricted for nearly three years—the Glaxo diabetes pill Avandia—and restoring it to full marketing status in the U.S.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news